DAIC

MARCH 13, 2024

CMS has reviewed the CardiAMP Heart Failure II Trial and approved the investigational product, related and routine items and services for purposes of Medicare coverage. The CardiAMP Heart Failure II Trial is FDA approved to enroll up to 250 patients at up to 40 clinical centers. said Peter Altman , PhD.,

CMS 111

CMS Heart Failure Reimbursement Quality of Life 111

Stroke: Vascular and Interventional Neurology

NOVEMBER 9, 2023

1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient 1.378]), and heart failure (1.282 [95%CI, 1.25‐1.315]).ConclusionPatient ConclusionPatient discharge disposition and comorbidities are driving factors in 90‐day readmissions following an ischemic stroke and differ from 30‐day readmissions.

Risk Factors 40

Risk Factors Strokes Stroke Medicare 40

CardiacWire

DECEMBER 10, 2023

A new study in European Heart Journal – Digital Health showed that Us2.ai’s ai’s AI echo algorithm can interpret echocardiographic strain images with similar accuracy as conventional measurements, highlighting how AI can democratize cardiac strain exams and improve heart failure assessments. in Taiwanese cohort; −15.4

Heart Failure 59

Heart Failure Reimbursement CMS Outpatient 59